Grigore I, Rajagopal A, Chow J, Stone T, Salmena L
Sci Rep. 2024; 14(1):27493.
PMID: 39528571
PMC: 11555236.
DOI: 10.1038/s41598-024-78337-y.
Lei Y, Shen H, Li Q, Yang S, Xie H, Li X
Aging (Albany NY). 2023; 15(10):4391-4410.
PMID: 37219449
PMC: 10258013.
DOI: 10.18632/aging.204742.
Guo X, Jiao H, Cao L, Meng F
Front Integr Neurosci. 2022; 16:989029.
PMID: 36479040
PMC: 9720134.
DOI: 10.3389/fnint.2022.989029.
Tian Q, Lu Y, Yan B, Wu C
Comput Math Methods Med. 2022; 2022:5211329.
PMID: 36128051
PMC: 9482681.
DOI: 10.1155/2022/5211329.
Zhang Y, Fan H, Zou C, Wei F, Sun J, Shang Y
Front Genet. 2022; 13:924802.
PMID: 36035134
PMC: 9412194.
DOI: 10.3389/fgene.2022.924802.
MicroRNA in Acromegaly: Involvement in the Pathogenesis and in the Response to First-Generation Somatostatin Receptor Ligands.
Henriques D, Lamback E, Dezonne R, Kasuki L, Gadelha M
Int J Mol Sci. 2022; 23(15).
PMID: 35955787
PMC: 9368811.
DOI: 10.3390/ijms23158653.
Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) modulates inhibitor of DNA binding 1 (ID1) to facilitate papillary thyroid carcinoma development by sponging microRNA-524-5p.
Liao G, Huang Z, Gan T, Wu C, Wang X, Li D
Bioengineered. 2022; 13(5):13201-13212.
PMID: 35635748
PMC: 9275871.
DOI: 10.1080/21655979.2022.2076498.
Ginsenoside Rh2 inhibits thyroid cancer cell migration and proliferation via activation of miR-524-5p.
Jiang S, Yan J, Chen X, Xie Q, Lin W, Lin T
Arch Med Sci. 2022; 18(1):164-170.
PMID: 35154537
PMC: 8826983.
DOI: 10.5114/aoms.2020.92871.
Spectrum of microRNAs and their target genes in cancer: intervention in diagnosis and therapy.
Dayakar A, Shanmukha K, Kalangi S
Mol Biol Rep. 2022; 49(7):6827-6846.
PMID: 35031927
DOI: 10.1007/s11033-021-07040-2.
MicroRNA‑524‑5p regulates the proliferation and invasion of HTR‑8/SVneo trophoblasts by targeting NUMB in the Notch signaling pathway.
Zheng L, Song J, Tang R, Chen X, Wang L, Wu D
Mol Med Rep. 2021; 23(6).
PMID: 33846809
PMC: 8060792.
DOI: 10.3892/mmr.2021.12075.
MicroRNA-935 Directly Targets FZD6 to Inhibit the Proliferation of Human Glioblastoma and Correlate to Glioma Malignancy and Prognosis.
Zhang D, Ma S, Zhang C, Li P, Mao B, Guan X
Front Oncol. 2021; 11:566492.
PMID: 33791198
PMC: 8006443.
DOI: 10.3389/fonc.2021.566492.
LncRNA TTN-AS1 Regulates miR-524-5p and RRM2 to Promote Breast Cancer Progression.
Feng H, Wang Q, Xiao W, Zhang B, Jin Y, Lu H
Onco Targets Ther. 2020; 13:4799-4811.
PMID: 32547107
PMC: 7261692.
DOI: 10.2147/OTT.S243482.
LncRNA MSC-AS1 aggravates nasopharyngeal carcinoma progression by targeting miR-524-5p/nuclear receptor subfamily 4 group A member 2 (NR4A2).
Yao H, Yang L, Tian L, Guo Y, Li Y
Cancer Cell Int. 2020; 20:138.
PMID: 32368184
PMC: 7189691.
DOI: 10.1186/s12935-020-01202-1.
The activation of GPER inhibits cells proliferation, invasion and EMT of triple-negative breast cancer via CD151/miR-199a-3p bio-axis.
Huang R, Li J, Pan F, Zhang B, Yao Y
Am J Transl Res. 2020; 12(1):32-44.
PMID: 32051735
PMC: 7013229.
Circulatory miRNA-484, 524, 615 and 628 expression profiling in HCV mediated HCC among Egyptian patients; implications for diagnosis and staging of hepatic cirrhosis and fibrosis.
El-Maraghy S, Adel O, Zayed N, Yosry A, El-Nahaas S, Gibriel A
J Adv Res. 2020; 22:57-66.
PMID: 31956442
PMC: 6961223.
DOI: 10.1016/j.jare.2019.12.002.
LINC00511 contributes to glioblastoma tumorigenesis and epithelial-mesenchymal transition via LINC00511/miR-524-5p/YB1/ZEB1 positive feedback loop.
Du X, Tu Y, Liu S, Zhao P, Bao Z, Li C
J Cell Mol Med. 2019; 24(2):1474-1487.
PMID: 31856394
PMC: 6991637.
DOI: 10.1111/jcmm.14829.
Upregulation of sphingosine kinase 1 is associated with recurrence and poor prognosis in papillary thyroid carcinoma.
Li J, Zhang B, Bai Y, Liu Y, Zhang B, Jin J
Oncol Lett. 2019; 18(5):5374-5382.
PMID: 31620198
PMC: 6788170.
DOI: 10.3892/ol.2019.10910.
The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease.
Candido S, Lupo G, Pennisi M, Basile M, Anfuso C, Petralia M
Oncol Rep. 2019; 42(3):911-922.
PMID: 31322245
PMC: 6682788.
DOI: 10.3892/or.2019.7215.
MicroRNA-524-5p suppresses the progression of papillary thyroid carcinoma cells via targeting on FOXE1 and ITGA3 in cell autophagy and cycling pathways.
Liu H, Chen X, Lin T, Chen X, Yan J, Jiang S
J Cell Physiol. 2019; 234(10):18382-18391.
PMID: 30941771
PMC: 6618135.
DOI: 10.1002/jcp.28472.
Expression Profile of Selected MicroRNAs in the Peripheral Blood of Multiple Sclerosis Patients: a Multivariate Statistical Analysis with ROC Curve to Find New Biomarkers for Fingolimod.
Eftekharian M, Komaki A, Mazdeh M, Arsang-Jang S, Taheri M, Ghafouri-Fard S
J Mol Neurosci. 2019; 68(1):153-161.
PMID: 30895441
DOI: 10.1007/s12031-019-01294-z.